Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
14.25    1.00 (7.55%)
Bid:
14.00
Ask:
14.50
Spread: 0.50 (3.571%)
Market Cap: £11.76m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Grant of Options

15 Nov 2018 12:37

RNS Number : 5087H
Frontier IP Group plc
15 November 2018
 

15 November 2018

 

Frontier IP Group plc

("Frontier IP" or the "Company")

 

Grant of Options

 

Frontier IP, which specialises in commercialising university intellectual property, announces that the Board has today granted options over ordinary shares of 10 pence each in the Company ("Ordinary Shares") to certain Executive Directors and personnel of the Company (the "Options").

 

The Options have been granted pursuant to the Company's share option scheme, the Frontier IP Group plc Employee Share Option Scheme 2011 as adopted by the Board of Directors of the Company on 30 November 2012 and amended by the Board of Directors of the Company on 26 March 2018. Certain of the Options have an exercise price of 65 pence, being the price at which the Company today completed a placing to raise £2.49 million, and certain Options have been granted at an exercise price of 10 pence, being the nominal value of an Ordinary Share.

 

The Options have been granted as follows:

 

Name

 

No. of Options granted with exercise price of 65p

No. of Options granted with exercise price of 10p

Total options over Ordinary Shares held following grant

Neil Crabb

50,000

95,000

1,204,000

Jackie McKay

47,000

89,000

631,000

Jim Fish

47,000

89,000

631,000

David Cairns

14,000

26,000

405,000

Matthew White

47,000

89,000

136,000

Other Company Personnel

87,000

151,000

630,000

Total Options granted

292,000

539,000

3,637,000

 

At the Company's 2017 AGM, the Board received the approval of shareholders for certain amendments to the Company's Employee Share Option Scheme 2011, including allowing the grant of options at nominal cost. The Options have been granted in line with the aim of the Company's remuneration policy which is to incentivise and reward appropriately in order to attract and retain the best people in support of the Group's strategy.

 

The exercise period commences on the third anniversary of the date of grant and expires on the day preceding the tenth anniversary thereof. Following today's grant, the Company now has a total of 3,637,000 options outstanding over Ordinary Shares, representing 9.5% of the Company's current issued share capital. Following the revisions to the Employee Share Option Scheme 2011 and the passing of the resolutions at the Company's 2017 AGM, the maximum number of Ordinary Shares that may be subject to options in any ten-year period is 15% of the issued ordinary share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Crabb

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

b)

LEI

213800BRYUKQPJWKJ312

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 10p each in Frontier IP Group Plc

 

Identification code (ISIN) for Frontier IP Group Plc ordinary shares: GB00B63PS212

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

65 pence

50,000

10 pence

95,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transactions

15 November 2018

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jackie McKay

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

b)

LEI

213800BRYUKQPJWKJ312

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 10p each in Frontier IP Group Plc

 

Identification code (ISIN) for Frontier IP Group Plc ordinary shares: GB00B63PS212

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

65 pence

47,000

10 pence

89,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transactions

15 November 2018

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jim Fish

2

Reason for the notification

a)

Position/status

Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

b)

LEI

213800BRYUKQPJWKJ312

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 10p each in Frontier IP Group Plc

 

Identification code (ISIN) for Frontier IP Group Plc ordinary shares: GB00B63PS212

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

65 pence

47,000

10 pence

89,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transactions

15 November 2018

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Cairns

2

Reason for the notification

a)

Position/status

Portfolio Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

b)

LEI

213800BRYUKQPJWKJ312

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 10p each in Frontier IP Group Plc

 

Identification code (ISIN) for Frontier IP Group Plc ordinary shares: GB00B63PS212

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

65 pence

14,000

10 pence

26,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transactions

15 November 2018

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew White

2

Reason for the notification

a)

Position/status

Director of Commercialisation (not a member of the board of directors)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

b)

LEI

213800BRYUKQPJWKJ312

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares of 10p each in Frontier IP Group Plc

 

Identification code (ISIN) for Frontier IP Group Plc ordinary shares: GB00B63PS212

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

65 pence

47,000

10 pence

89,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transactions

15 November 2018

f)

Place of the transaction

Outside a trading venue

 

 

The information set out in this announcement is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

Enquiries:

 

Frontier IP Group plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

M: 07464 546 025

www.frontierip.co.uk

Allenby Capital Limited (Nominated Adviser and Broker)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers (Corporate Finance)

Amrit Nahal (Equity Sales)

Notes to Editors:

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. The group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFVFLELELIT
Date   Source Headline
19th Jun 20267:00 amRNSResult of Retail Offer
17th Jun 20267:00 amRNSResult of Placing and Subscription
16th Jun 20265:20 pmRNSRetail Offer
16th Jun 20264:58 pmRNSProposed Placing and Subscription
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.